IBDEI08M ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11321,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,11321,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,11322,0)
 ;;=376.30^^73^703^30
 ;;^UTILITY(U,$J,358.3,11322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11322,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,11322,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,11322,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,11323,0)
 ;;=368.8^^73^703^7
 ;;^UTILITY(U,$J,358.3,11323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11323,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,11323,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,11323,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,11324,0)
 ;;=362.34^^73^703^5
 ;;^UTILITY(U,$J,358.3,11324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11324,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,11324,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,11324,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,11325,0)
 ;;=368.13^^73^703^87
 ;;^UTILITY(U,$J,358.3,11325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11325,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,11325,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,11325,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,11326,0)
 ;;=368.40^^73^703^112
 ;;^UTILITY(U,$J,358.3,11326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11326,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,11326,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,11326,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,11327,0)
 ;;=369.4^^73^703^58
 ;;^UTILITY(U,$J,358.3,11327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11327,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,11327,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,11327,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,11328,0)
 ;;=250.01^^73^703^21
 ;;^UTILITY(U,$J,358.3,11328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11328,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,11328,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,11328,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,11329,0)
 ;;=V08.^^73^703^40
 ;;^UTILITY(U,$J,358.3,11329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11329,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,11329,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,11329,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,11330,0)
 ;;=921.0^^73^703^16
 ;;^UTILITY(U,$J,358.3,11330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11330,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,11330,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,11330,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,11331,0)
 ;;=379.91^^73^703^86
 ;;^UTILITY(U,$J,358.3,11331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11331,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,11331,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,11331,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,11332,0)
 ;;=V58.69^^73^703^44
 ;;^UTILITY(U,$J,358.3,11332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11332,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,11332,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,11332,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,11333,0)
 ;;=871.4^^73^703^54
 ;;^UTILITY(U,$J,358.3,11333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11333,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,11333,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,11333,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,11334,0)
 ;;=242.90^^73^703^107
 ;;^UTILITY(U,$J,358.3,11334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11334,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,11334,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,11334,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,11335,0)
 ;;=135.^^73^703^100
 ;;^UTILITY(U,$J,358.3,11335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11335,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,11335,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,11335,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,11336,0)
 ;;=446.5^^73^703^106
 ;;^UTILITY(U,$J,358.3,11336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11336,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,11336,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,11336,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,11337,0)
 ;;=401.9^^73^703^49
 ;;^UTILITY(U,$J,358.3,11337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11337,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,11337,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,11337,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,11338,0)
 ;;=V72.0^^73^703^32
 ;;^UTILITY(U,$J,358.3,11338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11338,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,11338,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,11338,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,11339,0)
 ;;=V41.0^^73^703^90
 ;;^UTILITY(U,$J,358.3,11339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11339,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,11339,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,11339,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,11340,0)
 ;;=998.59^^73^703^88
 ;;^UTILITY(U,$J,358.3,11340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11340,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,11340,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,11340,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,11341,0)
 ;;=042.^^73^703^1
 ;;^UTILITY(U,$J,358.3,11341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11341,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,11341,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,11341,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,11342,0)
 ;;=053.29^^73^703^43
 ;;^UTILITY(U,$J,358.3,11342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11342,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,11342,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,11342,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,11343,0)
 ;;=054.40^^73^703^42
 ;;^UTILITY(U,$J,358.3,11343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11343,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,11343,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,11343,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,11344,0)
 ;;=190.1^^73^703^82
 ;;^UTILITY(U,$J,358.3,11344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11344,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11344,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,11344,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,11345,0)
 ;;=190.2^^73^703^50
 ;;^UTILITY(U,$J,358.3,11345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11345,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11345,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,11345,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,11346,0)
 ;;=190.7^^73^703^52
 ;;^UTILITY(U,$J,358.3,11346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11346,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,11346,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,11346,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,11347,0)
 ;;=202.81^^73^703^61
 ;;^UTILITY(U,$J,358.3,11347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11347,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,11347,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,11347,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,11348,0)
 ;;=215.9^^73^703^84
 ;;^UTILITY(U,$J,358.3,11348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11348,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,11348,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,11348,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,11349,0)
 ;;=224.2^^73^703^51
 ;;^UTILITY(U,$J,358.3,11349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11349,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11349,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,11349,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,11350,0)
 ;;=224.5^^73^703^95
 ;;^UTILITY(U,$J,358.3,11350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11350,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11350,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,11350,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,11351,0)
 ;;=224.7^^73^703^28
 ;;^UTILITY(U,$J,358.3,11351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11351,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,11351,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,11351,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,11352,0)
 ;;=237.70^^73^703^66
 ;;^UTILITY(U,$J,358.3,11352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11352,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,11352,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,11352,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,11353,0)
 ;;=239.6^^73^703^65
 ;;^UTILITY(U,$J,358.3,11353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11353,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,11353,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,11353,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,11354,0)
 ;;=239.81^^73^703^96
 ;;^UTILITY(U,$J,358.3,11354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11354,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,11354,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,11354,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,11355,0)
 ;;=272.0^^73^703^48
 ;;^UTILITY(U,$J,358.3,11355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11355,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,11355,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,11355,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,11356,0)
 ;;=340.^^73^703^63
 ;;^UTILITY(U,$J,358.3,11356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11356,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,11356,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,11356,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,11357,0)
 ;;=345.90^^73^703^29
 ;;^UTILITY(U,$J,358.3,11357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11357,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,11357,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,11357,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,11358,0)
 ;;=368.02^^73^703^23
 ;;^UTILITY(U,$J,358.3,11358,1,0)
 ;;=^358.31IA^4^2
